The findings were released Thursday by the American Society of Clinical Oncology and will be discussed at its annual meeting in Chicago
However, the absence of reported interactions does not constitute proof of safety in all contexts, especially for individuals with hepatic impairment, renal disease, or concurrent medications that affect glucose metabolism
the magnitude of HbA1c change in this non-diabetic population was modest, as would be expected Fasting insulin levels decreased, indicating improved insulin sensitivity Triglyceride and lipid profiles showed favourable changes, which may reduce cardiometabolic risk Waist circumference was substantially reduced, reflecting a decrease in visceral (abdominal) adiposity These findings are particularly relevant given that excess visceral fat is strongly associated with type 2 diabetes, cardiovascular disease, and metabolic syndrome
As more evidence emerges, the potential applications of glutathione IV therapy could expand, presenting exciting opportunities for improved health outcomes in various populations
If you already experience a higher heart rate as a side effect of your weight loss program, adding certain antihistamines might make that sensation more noticeable